Mark W. Bodmer
Hoofd Techniek/Wetenschap/O&O bij EVELO BIOSCIENCES, INC.
Vermogen: 1 184 $ op 30-04-2024
Actieve functies van Mark W. Bodmer
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
EVELO BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 19-01-2016 | - |
Loopbaan van Mark W. Bodmer
Eerdere bekende functies van Mark W. Bodmer
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
UCB | Corporate Officer/Principal | 01-01-2012 | 01-04-2016 |
The Bioindustry Association
The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Directeur/Bestuurslid | 01-04-2015 | 01-04-2016 |
Lorantis Ltd.
Lorantis Ltd. Pharmaceuticals: MajorHealth Technology Lorantis Ltd. used to discover and develop drugs. The company had discovered a fundamental immune mechanism, by which the immune response to any disease-causing antigen may be suppressed. It used pursue immunology drug discovery and development programmes to address unmet medical needs. Lorantis was founded in 1998 and was headquartered in Cambridge, UK | President | 01-01-1999 | 01-01-2004 |
Incyte Pharmaceuticals, Inc.
Incyte Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Incyte Pharmaceuticals, Inc. engages in the provision of biopharmaceutical services. The company was founded in April, 1991 is headquartered in Palo Alto, CA. | Hoofd Techniek/Wetenschap/O&O | 01-01-1998 | 01-01-1999 |
Hexagen Plc
Hexagen Plc BiotechnologyHealth Technology Part of Incyte Corp., Hexagen Plc develops technology for the discovery of single nucleotide polymorphisms. The British company was founded by Andrew Peter Sandham, Stephen William Bunting. Hexagen was acquired by Incyte Corp. on September 22, 1998 for $25.99 million. | Algemeen Directeur | - | - |
The Wellcome Trust Ltd.
The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Corporate Officer/Principal | - | - |
JPMorgan Partners Europe
JPMorgan Partners Europe Financial ConglomeratesFinance Part of JPMorgan Chase & Co., JPMorgan Partners Europe is a private equity group. The company is based in London, UK. | Corporate Officer/Principal | - | - |
Apax | Corporate Officer/Principal | - | - |
░░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | - |
Opleiding van Mark W. Bodmer
University of Cambridge | Doctorate Degree |
Statistieken
Internationaal
Verenigd Koninkrijk | 9 |
Verenigde Staten | 3 |
Zweden | 2 |
Operationeel
Corporate Officer/Principal | 5 |
President | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Sectoraal
Health Technology | 7 |
Finance | 3 |
Consumer Durables | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
EVELO BIOSCIENCES, INC. | Health Technology |
UCB | Health Technology |
Bedrijven in privébezit | 9 |
---|---|
Biotica Technology Ltd.
Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | Health Technology |
Lorantis Ltd.
Lorantis Ltd. Pharmaceuticals: MajorHealth Technology Lorantis Ltd. used to discover and develop drugs. The company had discovered a fundamental immune mechanism, by which the immune response to any disease-causing antigen may be suppressed. It used pursue immunology drug discovery and development programmes to address unmet medical needs. Lorantis was founded in 1998 and was headquartered in Cambridge, UK | Health Technology |
Incyte Pharmaceuticals, Inc.
Incyte Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Incyte Pharmaceuticals, Inc. engages in the provision of biopharmaceutical services. The company was founded in April, 1991 is headquartered in Palo Alto, CA. | Health Technology |
Schroder Ventures Holdings Plc
Schroder Ventures Holdings Plc Financial ConglomeratesFinance Part of Schroders Plc, Schroder Ventures Holdings Plc is a private equity firm. | Finance |
Apax | Consumer Durables |
JPMorgan Partners Europe
JPMorgan Partners Europe Financial ConglomeratesFinance Part of JPMorgan Chase & Co., JPMorgan Partners Europe is a private equity group. The company is based in London, UK. | Finance |
The Wellcome Trust Ltd.
The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Miscellaneous |
The Bioindustry Association
The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Commercial Services |
Hexagen Plc
Hexagen Plc BiotechnologyHealth Technology Part of Incyte Corp., Hexagen Plc develops technology for the discovery of single nucleotide polymorphisms. The British company was founded by Andrew Peter Sandham, Stephen William Bunting. Hexagen was acquired by Incyte Corp. on September 22, 1998 for $25.99 million. | Health Technology |
- Beurs
- Insiders
- Mark W. Bodmer
- Ervaring